High-Dose Thiotepa and Etoposide-Based Regimens With Autologous Hematopoietic Support for High-Risk or Recurrent CNS Tumors in Children and Adults
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1701408
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 1998
Authors
Publisher
Springer Science and Business Media LLC